EFS

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

EFS

Sep 2, 2024, 17:17 | Insight

Jarushka Naidoo: Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials

Jarushka Naidoo shared a post on X: "Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early…

Jul 21, 2024, 21:49 | Blog

Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…

Apr 17, 2024, 18:39 | Insight

Aruni Ghose: The stellar Giuseppe Banna with his stellar mentee Mona Hassan led this magnificent SR and MA

Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust and Focused Topic Network Member…

Apr 11, 2024, 15:15 | Insight

Talha Badar: Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia

Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: “Efficacy of autologous and…

Oct 28, 2023, 16:36 | Insight

Vinay Prasad: The most interesting thing you'll read about PFS, EFS, DFS in oncology this year

Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post by…

All: 5 Posts: 1 - 100